Sylatron Drug Interactions
Currently displaying a list of 227 drugs known to interact with Sylatron (peginterferon alfa-2b).
- 41 major drug interactions
- 182 moderate drug interactions
- 4 minor drug interactions
Medications known to interact with Sylatron
Note: Showing generic names only.
A
- adalimumab
- ado-trastuzumab emtansine
- alemtuzumab
- amifampridine
- aminophylline
- amiodarone
- anisindione
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atezolizumab
- atorvastatin
- auranofin
- aurothioglucose
- avatrombopag
- avelumab
- axicabtagene ciloleucel
- azathioprine
B
- baricitinib
- bedaquiline
- benznidazole
- bexarotene
- black cohosh
- bortezomib
- brentuximab
- brexucabtagene autoleucel
- bupropion
C
- cabazitaxel
- calaspargase pegol
- cannabidiol
- carboplatin
- carfilzomib
- cemiplimab
- cerivastatin
- certolizumab
- chloramphenicol
- chloramphenicol ophthalmic
- chloramphenicol otic
- chloroquine
- ciltacabtagene autoleucel
- cisplatin
- cladribine
- clofarabine
- clozapine
- colchicine
- cosibelimab
- crizotinib
- cyclophosphamide
D
- daclizumab
- dapsone
- deferiprone
- denosumab
- deucravacitinib
- dicumarol
- didanosine
- dimethyl fumarate
- dinutuximab
- diroximel fumarate
- disulfiram
- docetaxel
- dostarlimab
- doxorubicin
- doxorubicin liposomal
- durvalumab
E
- efavirenz
- efbemalenograstim alfa
- eflapegrastim
- elotuzumab
- elranatamab
- eltrombopag
- enfortumab vedotin
- epirubicin
- eribulin
- etanercept
- ethambutol
- ethionamide
- etoposide
- etranacogene dezaparvovec
- etrasimod
- etravirine
- evening primrose
F
- fenfluramine
- fezolinetant
- fidanacogene elaparvovec
- filgrastim
- fingolimod
- fludarabine
- fluphenazine
- fluvastatin
G
H
I
- idecabtagene vicleucel
- idelalisib
- infliximab
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- interferon beta-1a
- interferon beta-1b
- iodoquinol
- iohexol
- iomeprol
- iopamidol
- ipilimumab
- isoniazid
- ixabepilone
- ixazomib
K
L
- leflunomide
- levodopa
- levoketoconazole
- lindane topical
- linezolid
- lisocabtagene maraleucel
- lomitapide
- loncastuximab tesirine
- lovastatin
M
- melatonin
- methadone
- methotrexate
- metrizamide
- metronidazole
- mipomersen
- mirvetuximab soravtansine
- monomethyl fumarate
- mosunetuzumab
N
O
P
- paclitaxel
- paclitaxel protein-bound
- palifermin
- pegaspargase
- pegfilgrastim
- peginterferon alfa-2a
- peginterferon beta-1a
- pegloticase
- pegvaliase
- pembrolizumab
- pexidartinib
- pimozide
- pitavastatin
- pitolisant
- polatuzumab vedotin
- polyethylene glycol 3350 with electrolytes
- pomalidomide
- ponatinib
- ponesimod
- pravastatin
R
- radium 223 dichloride
- ramelteon
- rasagiline
- red yeast rice
- remdesivir
- repotrectinib
- retifanlimab
- rifampin
- ritlecitinib
- roflumilast
- roflumilast topical
- ropeginterferon alfa-2b
- ropinirole
- rosuvastatin
S
- samarium sm 153 lexidronam
- sargramostim
- secnidazole
- selinexor
- simvastatin
- siponimod
- sipuleucel-T
- sodium phosphate p32
- stavudine
- stiripentol
- strontium-89 chloride
T
- talquetamab
- tarlatamab
- tbo-filgrastim
- teclistamab
- telbivudine
- teniposide
- teriflunomide
- thalidomide
- theophylline
- thioguanine
- tinidazole
- tisagenlecleucel
- tislelizumab
- tisotumab vedotin
- tizanidine
- tocilizumab
- tofacitinib
- topotecan
- toripalimab
- trabectedin
- tramadol
- tremelimumab
U
V
- valganciclovir
- valoctocogene roxaparvovec
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- voclosporin
W
Z
Sylatron disease interactions
There are 20 disease interactions with Sylatron (peginterferon alfa-2b) which include:
- renal dysfunction
- autoimmune diseases
- cardiac disease
- CNS dysfunction
- depression
- thyroid dysfunction
- autoimmune hepatitis
- depression
- severe hepatic disease
- hemoglobinopathies
- renal dysfunction
- colitis
- diabetes mellitus
- myelosuppression
- peripheral neuropathy
- bone marrow suppression
- endocrine disorders
- ophthalmological disorders
- pancreatitis
- pulmonary disorders
More about Sylatron (peginterferon alfa-2b)
- Sylatron consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antineoplastic interferons
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.